These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 25257790)
21. Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms. Charette N; De Saeger C; Horsmans Y; Leclercq I; Stärkel P Cell Death Dis; 2013 Jan; 4(1):e471. PubMed ID: 23348585 [TBL] [Abstract][Full Text] [Related]
22. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590 [TBL] [Abstract][Full Text] [Related]
23. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells. Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206 [TBL] [Abstract][Full Text] [Related]
24. A moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells. Lin T; Wan L; Qi X; Shi W; Lin J Bioelectromagnetics; 2014 Jul; 35(5):337-46. PubMed ID: 24619849 [TBL] [Abstract][Full Text] [Related]
25. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells. Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939 [TBL] [Abstract][Full Text] [Related]
26. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest. He SQ; Rehman H; Gong MG; Zhao YZ; Huang ZY; Li CH; Zhang WG; Chen XP Cancer Biol Ther; 2007 Aug; 6(8):1247-57. PubMed ID: 17700059 [TBL] [Abstract][Full Text] [Related]
27. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins. Yang L; Wang Q; Li D; Zhou Y; Zheng X; Sun H; Yan J; Zhang L; Lin Y; Wang X Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323 [TBL] [Abstract][Full Text] [Related]
28. Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin. Yoon MJ; Park SS; Kang YJ; Kim IY; Lee JA; Lee JS; Kim EG; Lee CW; Choi KS Carcinogenesis; 2012 Mar; 33(3):492-500. PubMed ID: 22159225 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death. Park SJ; Jo DS; Jo SY; Shin DW; Shim S; Jo YK; Shin JH; Ha YJ; Jeong SY; Hwang JJ; Kim YS; Suh YA; Chang JW; Kim JC; Cho DH Oncotarget; 2016 Oct; 7(40):65957-65967. PubMed ID: 27602754 [TBL] [Abstract][Full Text] [Related]
30. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA. Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells. Abdollahi T; Robertson NM; Abdollahi A; Litwack G Apoptosis; 2005 Dec; 10(6):1383-93. PubMed ID: 16215677 [TBL] [Abstract][Full Text] [Related]
32. Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules. Taniguchi H; Horinaka M; Yoshida T; Yano K; Goda AE; Yasuda S; Wakada M; Sakai T Mol Cancer Ther; 2012 Oct; 11(10):2294-300. PubMed ID: 22784708 [TBL] [Abstract][Full Text] [Related]
33. The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL. Plissonnier ML; Fauconnet S; Bittard H; Lascombe I PLoS One; 2011; 6(12):e28354. PubMed ID: 22174792 [TBL] [Abstract][Full Text] [Related]
34. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. Hari Y; Harashima N; Tajima Y; Harada M Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422 [TBL] [Abstract][Full Text] [Related]
35. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice. Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661 [TBL] [Abstract][Full Text] [Related]
36. Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. Kang YJ; Kim IY; Kim EH; Yoon MJ; Kim SU; Kwon TK; Choi KS Exp Mol Med; 2011 Jan; 43(1):24-34. PubMed ID: 21150246 [TBL] [Abstract][Full Text] [Related]
37. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin. Tse AK; Cao HH; Cheng CY; Kwan HY; Yu H; Fong WF; Yu ZL J Invest Dermatol; 2014 May; 134(5):1397-1407. PubMed ID: 24213373 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagy. Babazadeh SM; Zolfaghari MR; Zargar M; Baesi K; Hosseini SY; Ghaemi A BMC Cancer; 2023 Jun; 23(1):519. PubMed ID: 37280571 [TBL] [Abstract][Full Text] [Related]
39. Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells. Xu Y; Gao CC; Pan ZG; Zhou CW Biochem Biophys Res Commun; 2018 Feb; 496(3):998-1005. PubMed ID: 29305260 [TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest. Lu M; Kwan T; Yu C; Chen F; Freedman B; Schafer JM; Lee EJ; Jameson JL; Jordan VC; Cryns VL J Biol Chem; 2005 Feb; 280(8):6742-51. PubMed ID: 15569667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]